Drug discovery consultancy
Differding Consulting offers its customers advice on medicinal chemistry and drug discovery projects, and on strategic orientations in research.
The value of our Drug Discovery Consultancy services is based on:
- Extensive experience in drug discovery from hit finding through to development candidate nomination
- Proven track record in building and managing a multisite, multinational medicinal chemistry department, and successful delivery of new compounds into development
- Significant experience in integrating and optimizing research activities after acquisition
- Extensive experience in successfully outsourcing chemistry activities from tactical to strategic initiatives
- Proven record in directing implementation of new technologies – combinatorial chemistry/parallel synthesis, compound library management, high throughput screening
- Good knowledge of Biology, Pharmacology and ADME
- Good communication and interpersonal skills
- Fluency in English, French and German – written and spoken
02.06.2017 | THE DRUG DISCOVERY AND DEVELOPMENT INDUSTRY IN INDIA - TWO DECADES OF PROPRIETARY SMALL-MOLECULE R&D
A comprehensive survey of proprietary drug discovery and development efforts by Indian companies between 1994 and mid-2016, focusing on preclinical and clinical development compounds by company, therapeutic indication, mode of action, target class, and development status. The analysis includes the evolution of the overall pipeline over two decades, attrition rates, in-house developments and contributions to Western pharmaceutical pipelines through licensing agreements.
AVAILABLE OPEN ACCESS
28.01.2018 | THE STORY OF INDIAN PHARMA AND BIOTECH - BOOKS TO READ
For all those who are interested in the recent history of the pharmaceutical and biotechnology industry in India, and who want to go beyond annual reports and corporate presentations, four recently published biographies are must-reads. Whereas three books are autobiographies, a fourth one is the result of countless interviews of key players (scientists, current and past coworkers, pharma rivals, ministries, etc…), and gives unique insights into the development of biotechnology in India.